NYSE American - Nasdaq Real Time Price USD

Perspective Therapeutics, Inc. (CATX)

3.4250
+0.1000
+(3.01%)
As of 9:54:02 AM EDT. Market Open.
Currency in USD All numbers in thousands
Download
Breakdown
TTM
12/31/2024
12/31/2023
6/30/2022
6/30/2021
Total Revenue
0
0
0
10,795
10,053
Cost of Revenue
--
--
--
6,179
4,932
Gross Profit
--
--
--
4,616
5,121
Operating Expense
75,624
66,797
40,941
12,007
8,558
Operating Income
-75,624
-66,797
-40,941
-7,391
-3,437
Net Non Operating Interest Income Expense
11,541
10,467
852
119
59
Other Income Expense
-22,696
-24,097
-17
--
-9
Pretax Income
-86,779
-80,427
-40,106
-7,272
-3,387
Tax Provision
--
-2,097
-2,651
--
--
Net Income Common Stockholders
-85,172
-79,279
-46,508
-7,272
-3,390
Diluted NI Available to Com Stockholders
-85,172
-79,279
-46,508
-7,272
-3,390
Basic EPS
-1.23
-1.23
-1.74
-0.50
-0.30
Diluted EPS
-1.23
-1.23
-1.74
-0.50
-0.30
Basic Average Shares
70,136.7500
64,425
26,764
14,198.7000
10,384.1000
Diluted Average Shares
70,136.7500
64,425
26,764
14,198.7000
10,384.1000
Total Operating Income as Reported
-99,713
-90,886
-40,941
-7,391
-3,446
Total Expenses
75,624
66,797
40,941
18,186
13,490
Net Income from Continuing & Discontinued Operation
-85,172
-79,279
-46,508
-7,272
-3,387
Normalized Income
-60,593
-54,869.0805
-37,455
-7,272
-3,378
Interest Income
11,688
10,515
934
119
59
Interest Expense
147
48
82
--
--
Net Interest Income
11,541
10,467
852
119
59
EBIT
-86,632
-80,379
-40,024
-7,391
-3,437
EBITDA
-83,950
-78,073
-39,038
-7,143
-3,288
Reconciled Cost of Revenue
--
--
--
6,179
4,932
Reconciled Depreciation
2,682
2,306
986
248
149
Net Income from Continuing Operation Net Minority Interest
-84,682
-78,330
-37,455
-7,272
-3,387
Total Unusual Items Excluding Goodwill
-24,089
-24,089
0
0
-9
Total Unusual Items
-24,089
-24,089
0
0
-9
Normalized EBITDA
-59,861
-53,984
-39,038
-7,143
-3,279
Tax Rate for Calcs
0
0
0.0001
0
0
Tax Effect of Unusual Items
0
-628.0805
0
0
0
6/30/2021 - 11/10/2005

Upgrade to begin using 40 years of financial statements and get so much more.

Perform in-depth fundamental analysis with decades of income statements, balance sheets, and cash flows — all exportable.

Upgrade

Related Tickers

CERS Cerus Corporation
1.4450
-4.30%
 
HYPR Hyperfine, Inc.
0.7701
-3.28%
 
RSLS ReShape Lifesciences Inc.
2.4100
-42.34%
 
BJDX Bluejay Diagnostics, Inc.
2.1168
-5.91%
 
HSDT Helius Medical Technologies, Inc.
0.8000
-26.61%
 
VERO Venus Concept Inc.
3.1720
-0.25%
 
PTHL Pheton Holdings Ltd
14.05
+4.07%
 
BSGM BioSig Technologies, Inc.
6.28
-14.32%
 
IINN Inspira Technologies Oxy B.H.N. Ltd.
0.7100
-2.14%
 
ALUR Allurion Technologies Inc.
2.5700
-3.75%